Ischemia targeted coronary revascularization improves 5-year survival following carotid endarterectomy
Journal of Vascular Surgery · 2025
DOI: 10.1016/j.jvs.2025.03.197 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Dainis Krievins und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Vascular Surgery, Pauls Stradins Clinical University Hospital, Riga, Latvia; Faculty of Medicine, University of Latvia, Riga, Latvia. E…. Hauptthemen laut MEDLINE: Endarterectomy, Carotid, Carotid Stenosis, Coronary Artery Disease. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Latvijas Zinātnes Padome, Ministry of Education and Science.
Abstract (Originalsprache)
OBJECTIVES: Long-term survival after carotid endarterectomy (CEA) is limited by adverse cardiac events with 5% annual mortality. We sought to determine whether diagnosis of silent coronary ischemia together with elective ischemia-targeted coronary revascularization can reduce death and myocardial infarction (MI) and improve long-term survival of patients after CEA. METHODS: Observational cohort study of patients with no cardiac history or coronary symptoms undergoing elective CEA. Patients enrolled in a prospective study of preoperative cardiac evaluation using coronary computed tomography-derived fractional flow reserve (FFRCT) to detect silent (asymptomatic) coronary ischemia together with elective postoperative ischemia-targeted coronary revascularization were compared with matched controls with standard preoperative cardiac evaluation and no elective coronary revascularization. Lesion-specific coronary ischemia was defined as an FFRCT of ≤0.80 distal to >30% stenosis with severe ischemia defined as an FFRCT of ≤0.75. End points included all-cause death, cardiac death, MI, stroke, and major adverse cardiovascular events (MACE) (defined as cardiovascular death, MI, or stroke) during 5 years of follow-up. RESULTS: FFRCT (n = 100) and control (n = 100) cohorts were well-matched with no significant differences in age, gender, comorbidities, or indications for CEA. Asymptomatic lesion-specific coronary ischemia (FFRCT of ≤0.80) was present in 57% of FFRCT patients, with severe ischemia in 44% and left main ischemia in 7%; 43% had no coronary ischemia (FFRCT of >0.80). The status of coronary ischemia was unknown in the controls. CEA was performed successfully in both cohorts with no deaths or neurological events, and all patients received optimal postoperative medical therapy. Elective ischemia-targeted coronary revascularization was performed in 33% of FFRCT patients within 3 months of CEA. Controls had no elective coronary revascularization. During 5 years of follow-up, compared with controls, the FFRCT group had fewer all-cause deaths (11% vs 24%; hazard ratio [HR], 0.37; 95% confidence interval [CI], 0.17-0.77; P = .016); fewer cardiac deaths (3% vs 13%; HR, 0.15; 95% CI, 0.03-0.69; P = .009); fewer MIs (3% vs 21%; HR, 0.07; 95% CI, 0.02-0.31; P 0.80). Annual mortality in FFRCT was 2.2% per year compared with 4.8% per year in controls. CONCLUSIONS: Diagnosis of silent coronary ischemia together with elective ischemia-targeted coronary revascularization after CEA decrease the 5-year risk of all-cause death, cardiac death, MI, and MACE by >50% and improved survival (89%) compared with patients receiving standard cardiac evaluation and care (76%).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Vascular Surgery, Pauls Stradins Clinical University Hospital, Riga, Latvia; Faculty of Medicine, University of Latvia, Riga, Latvia. Electronic address: dainis.krievins@stradini.lv.
- Department of Vascular Surgery, Pauls Stradins Clinical University Hospital, Riga, Latvia; Faculty of Medicine, University of Latvia, Riga, Latvia.
- Department of Vascular Surgery, Pauls Stradins Clinical University Hospital, Riga, Latvia; Faculty of Medicine, Riga Stradins University, Riga, Latvia.
- Department of Vascular Surgery, Pauls Stradins Clinical University Hospital, Riga, Latvia.
- Faculty of Medicine, University of Latvia, Riga, Latvia.
- Faculty of Medicine, University of Latvia, Riga, Latvia; Department of Vascular Surgery, Riga East Clinical University Hospital, Riga, Latvia.
Förderung
- Latvijas Zinātnes Padome
- Ministry of Education and Science
Zitieren
APA
Krievins, D., Jegere, S., Latkovskis, G., Lacis, A., Zellans, E., Kumsars, I., Putrins, D., Vetra, J., Supols, E., Zvaigzne, L., Kirsners, A., Erglis, A., Ivanova, P., Jurkans, J., & Zarins, C. K. (2025). Ischemia targeted coronary revascularization improves 5-year survival following carotid endarterectomy. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.03.197
Vancouver
Krievins D, Jegere S, Latkovskis G, Lacis A, Zellans E, Kumsars I, et al. Ischemia targeted coronary revascularization improves 5-year survival following carotid endarterectomy. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.03.197
BibTeX
@article{Krievins2025,
author = {Krievins, Dainis and Jegere, Sanda and Latkovskis, Gustavs and Lacis, Aigars and Zellans, Edgars and Kumsars, Indulis and Putrins, Davis and Vetra, Janis and Supols, Edgars and Zvaigzne, Ligita and Kirsners, Arnis and Erglis, Andrejs and Ivanova, Patricija and Jurkans, Janis and Zarins, Christopher K},
title = {Ischemia targeted coronary revascularization improves 5-year survival following carotid endarterectomy},
journal = {Journal of Vascular Surgery},
year = {2025},
doi = {10.1016/j.jvs.2025.03.197}
}
EUVIMED